LAULETTA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 5.680
AS - Asia 2.224
EU - Europa 1.862
SA - Sud America 511
AF - Africa 80
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.360
Nazione #
US - Stati Uniti d'America 5.573
SG - Singapore 976
IT - Italia 625
CN - Cina 550
BR - Brasile 411
SE - Svezia 311
HK - Hong Kong 235
RU - Federazione Russa 193
DE - Germania 164
FI - Finlandia 113
UA - Ucraina 113
VN - Vietnam 107
FR - Francia 105
GB - Regno Unito 101
IN - India 74
BD - Bangladesh 62
CA - Canada 56
AR - Argentina 40
TR - Turchia 35
MX - Messico 32
ID - Indonesia 30
IQ - Iraq 23
JP - Giappone 23
PL - Polonia 22
ES - Italia 21
BE - Belgio 20
ZA - Sudafrica 18
NL - Olanda 17
PK - Pakistan 17
CI - Costa d'Avorio 15
CO - Colombia 15
IE - Irlanda 15
MA - Marocco 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
AT - Austria 11
PH - Filippine 11
VE - Venezuela 11
MY - Malesia 9
JO - Giordania 8
LT - Lituania 8
CL - Cile 7
CZ - Repubblica Ceca 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
BO - Bolivia 6
EC - Ecuador 6
EG - Egitto 6
AZ - Azerbaigian 5
PA - Panama 5
BH - Bahrain 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
NI - Nicaragua 4
UY - Uruguay 4
DZ - Algeria 3
JM - Giamaica 3
KR - Corea 3
MU - Mauritius 3
TH - Thailandia 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.359
Città #
Fairfield 623
Ashburn 586
Singapore 535
San Jose 416
Chandler 414
Woodbridge 392
Milan 255
Seattle 255
Cambridge 252
Jacksonville 247
Houston 240
Nyköping 238
Hong Kong 234
Beijing 196
Wilmington 189
Ann Arbor 172
New York 98
Rome 94
Lauterbourg 80
Roxbury 76
Lawrence 73
Los Angeles 72
Nanjing 70
Dallas 68
Santa Clara 64
Boardman 53
Des Moines 53
Bari 50
Brooklyn 46
Helsinki 46
Princeton 46
Munich 38
Inglewood 37
São Paulo 34
Columbus 31
San Diego 29
Buffalo 26
Ho Chi Minh City 25
Nanchang 24
Hebei 23
Tokyo 23
Figino 22
London 22
Brussels 20
Dong Ket 20
Hanoi 20
Shenyang 20
Toronto 20
Montreal 19
Council Bluffs 18
Jakarta 18
Denver 16
Falkenstein 16
Warsaw 16
Abidjan 15
Jiaxing 15
Dublin 14
Pune 14
San Francisco 14
Tianjin 14
Frankfurt am Main 13
Orem 13
Ankara 12
Belo Horizonte 12
Boston 12
Moscow 12
Phoenix 12
Tashkent 12
Turin 12
Changsha 11
Chicago 11
Atlanta 10
Guangzhou 10
Jinan 10
Stockholm 10
The Dalles 10
Chennai 9
Grafing 9
Nuremberg 9
Paris 9
Amman 8
Baghdad 8
Charlotte 8
Guarulhos 8
Ostuni 8
Poplar 8
Shanghai 8
Casablanca 7
Haiphong 7
Johannesburg 7
Kuala Lumpur 7
Rio de Janeiro 7
Amsterdam 6
Brno 6
Curitiba 6
Dearborn 6
Elk Grove Village 6
Falls Church 6
Hounslow 6
Jeddah 6
Totale 7.213
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 227
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 218
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 203
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 202
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 201
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 196
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 196
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 180
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 162
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 160
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 159
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 157
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 154
Hepatitis C virus infection and mixed cryoglobulinemia 152
B-cell depletion in the treatment of mixed cryoglobulinemia. 151
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 149
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 146
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 146
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 145
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 143
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 142
Barrett's esophagus and esophageal cancer: An overview. 138
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 135
A Challenging Case of Visceral Leishmaniasis 134
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 134
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 134
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 133
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 132
H. pylori infection and gastric cancer: state of the art (review). 130
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 129
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 129
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 127
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 126
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 123
null 122
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 120
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 120
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 119
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 118
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 117
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 116
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 115
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 113
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 110
Crioglobulinemia mista e infezione da HCV 110
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 110
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 109
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 108
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 108
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 108
Cryoglobulinemic Vasculitis 107
Alcolizzazione percutanea del piccolo HCC. Casistica personale 101
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 101
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 99
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 99
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 98
Vasculiti primarie sistemiche 96
null 96
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 95
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 95
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 93
In reply. Transarterial chemoembolization plus sorafenib... 91
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 91
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 89
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 87
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 86
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 86
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 85
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 84
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 82
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 82
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 81
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 79
null 78
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 76
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 74
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 72
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 72
La vasculite crioglobulinemica: aspetti clinico-patogenetici 70
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 66
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 65
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 65
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 62
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 62
null 61
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 60
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 60
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 59
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 54
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 54
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 50
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 50
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 49
null 47
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 41
Terapia della sindrome crioglobulinemica 35
Totale 10.601
Categoria #
all - tutte 43.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022661 48 89 9 23 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.595 35 25 131 44 31 147 200 140 58 79 235 470
2025/20263.555 475 158 156 331 401 196 436 80 435 277 146 464
2026/202793 93 0 0 0 0 0 0 0 0 0 0 0
Totale 10.601